it's a particular type of play I've sometimes had success with and sometimes not so much. The float remains miniscule even after this small offering, they're presenting at a conference tues. & with phase 3 data due in 2Q (I mistakenly said 2H in a prev. post) they presumably could announce something that's perceived as significant producing action like we saw recently ...at least for an hour or two. If not I'll be happy with another 10 - 20% from here.
As for what I think of the co.? I no longer hang my hat on any bio, especially until the sector can catch a bid again.
They have a decent looking pipeline with another catalyst, a Phase 2 this time, due sometime in 2017, maybe I'll revisit then. If it turns out they're on to something and I miss out, that will be the rule rather than the exception with me and I'll keep lumbering on.
News 
Market Data 
Discover 
